Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Revenue

Gulf Pharmaceutical Industries P.S.C. had revenue of 273.40M AED in the quarter ending March 31, 2026, a decrease of -3.02%. This brings the company's revenue in the last twelve months to 1.07B, up 13.84% year-over-year. In the year 2025, Gulf Pharmaceutical Industries P.S.C. had annual revenue of 1.08B with 8.40% growth.

• Revenue (ttm): 1.07B
• Revenue Growth: +13.84%
• P/S Ratio: 1.15
• Revenue / Employee: 444.58K
• Employees: 2,400
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.08B	83.30M	8.40%
Dec 31, 2024	992.20M	-285.30M	-22.33%
Dec 31, 2023	1.28B	-338.60M	-20.95%
Dec 31, 2022	1.62B	472.90M	41.37%
Dec 31, 2021	1.14B	570.20M	99.51%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error